This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment ...

For plaque psoriasis ... week. Humira is available in a starter kit that helps you follow this dosing schedule. The kit contains prefilled Humira pens. When Humira is used to treat uveitis ...

AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

Opens in a new tab or window Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread adoption. This analysis involving patients in the ...

BE SURE is a phase 3, randomised, double-blind study comparing bimekizumab to Humira in adult patients with moderate-to-severe chronic plaque psoriasis. The co-primary endpoints of the study were ...

Humira’s success is down to its incredible versatility – an anti-TNF drug, it is approved in a range of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis and Crohn’s ...

Infliximab is more effective and safer than etanercept in the treatment of patients with noninfectious uveitis. Adalimumab is valid for severe uveitis, reducing efficacy for treatment of infliximab.

Two adalimumab biosimilars (Amjevita and Imraldi) worked as well for moderate to severe psoriasis as the original brand-name ...

Infliximab is more effective and safer than etanercept in the treatment of patients with noninfectious uveitis. Adalimumab is valid for severe uveitis, reducing efficacy for treatment of infliximab.